Theravance Biopharma Inc (0TB) — Strategic Asset Allocation Index
Theravance Biopharma Inc (0TB) has a Strategic Asset Allocation Index of 1.3% as of September 2025. Strategic assets (PP&E of €- plus long-term investments of €3.03 Million) total €3.03 Million, measured against net assets of €232.68 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Theravance Biopharma Inc's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Theravance Biopharma Inc Strategic Asset Allocation Index (2014–2022)
This chart shows how Theravance Biopharma Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2014 to 2022. As of September 2025, the index stands at 1.3%, representing strategic assets of €3.03 Million against net assets of €232.68 Million EUR. For live market cap and overall valuation, see 0TB market cap.
Annual Strategic Asset Allocation Index for Theravance Biopharma Inc (2014–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Theravance Biopharma Inc from 2014 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Theravance Biopharma Inc shareholders equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 11.8% | €52.00 Million | €52.00 Million | €0.00 | €441.80 Million | ▼ -33.2 pp |
| 2017 | 44.9% | €51.74 Million | €10.16 Million | €41.59 Million | €115.18 Million | ▲ +14.1 pp |
| 2016 | 30.8% | €108.03 Million | €8.46 Million | €99.56 Million | €350.23 Million | ▲ +5.9 pp |
| 2015 | 25.0% | €60.73 Million | €9.87 Million | €50.86 Million | €243.06 Million | ▲ +3.9 pp |
| 2014 | 21.1% | €61.06 Million | €9.66 Million | €51.40 Million | €289.79 Million | — |